EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Mirtazapine Induces Lipocalin-Type Prostaglandin D Synthase Expression in Brain Pericytes

Aya Narita, Akiko Nakano-Doi, Ryo Nishiyama, Toshinori Sawano, Kazuaki Fukushima, Tomohiro Matsuyama, Takayuki Nakagomi iD

Biomolecules · 24.06.2026 · 16 (7) · 945

DOI: 10.3390/biom16070945 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, online erschienen am 24.06.2026. Verfasst von Aya Narita und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Advanced Medical Sciences, Hyogo Medical University, 1-1 Mukogawacho, Nishinomiya 663-8501, Japan. Hauptthemen laut MEDLINE: Lipocalins, Intramolecular Oxidoreductases, Pericytes, Brain. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science (JSPS) KAKENHI, Hyogo Medical University Diversity Grant for Research Promotion, MEXT Funds for the Development of Human Resources in Science and Technology, “Initiative for Realizing Diversity in the Research Environment (Characteristic-Co….

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The brain maintains homeostasis partially by scavenging waste products. Failure of this function is closely associated with the onset and pathogenesis of various brain diseases, such as Alzheimer’s disease, sleep disorder, and the delay of the reparative process after brain injuries. We recently demonstrated that brain pericytes (BPCs) are sources of lipocalin-type prostaglandin D synthase (L-PGDS), a waste scavenger, in the brain. Based on the above, chemical compounds which promote L-PGDS production could have potential against brain diseases, such as dementia, sleep disorders, and brain injuries. However, the specific chemical compounds that may enhance L-PGDS production in BPCs have not yet been identified. In this study, we explored 158 chemical compounds from FDA-approved drug libraries with these activities. qPCR analysis showed that mirtazapine (MTZ), a noradrenergic and specific serotonergic antidepressant, can increase L-PGDS expression in BPCs as well as in mouse- (m-BPCs) and human-derived BPCs (h-BPCs) in a dose-dependent manner. Since L-PGDS is a secretory protein, m-BPCs and h-BPCs were treated with various MTZ doses and L-PGDS levels in the culture supernatant were investigated. Western blot analysis showed that L-PGDS levels were significantly increased in a dose-dependent manner in both cell types, indicating that MTZ promoted L-PGDS secretion from m-BPCs and h-BPCs. Thus, MTZ may have the potential to be applied as drug repositioning for various brain diseases other than depression by activating L-PGDS production in BPCs, highlighting the importance of BPCs as the source to maintain brain homeostasis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LipocalinsIntramolecular OxidoreductasesPericytesBrainMirtazapineAnimalsHumansMice

Stichwörter der Autor:innen

Alzheimer’s diseasebrain pericytescerebrovascular diseasechemical compoundsglymphatic system’s perivascular tunnelslipocalin-type prostaglandin D synthasemirtazapinesleep disorderwaste scavenger

Substanzen

LipocalinsIntramolecular Oxidoreductasesprostaglandin R2 D-isomeraseMirtazapine

Autor:innen und Institutionen

  • Institute for Advanced Medical Sciences, Hyogo Medical University, 1-1 Mukogawacho, Nishinomiya 663-8501, Japan.
  • Department of Therapeutic Progress in Brain Diseases, Hyogo Medical University, 1-1 Mukogawacho, Nishinomiya 663-8501, Japan.
  • Research Center for Advanced Medical Science, Dokkyo Medical University, 880 Kitakobayashi, Mibu-machi, Shimotsuga-gun, Tochigi 321-0293, Japan.
  • Department of Biomedical Sciences, Ritsumeikan University, 1-1-1 Nojihigashi, Kusatsu 525-8577, Japan.
  • Department of Chemistry, Hyogo Medical University, 1-1 Mukogawacho, Nishinomiya 663-8501, Japan.

ORCID-Profile: Takayuki Nakagomi

Förderung

  • Japan Society for the Promotion of Science (JSPS) KAKENHI
  • Hyogo Medical University Diversity Grant for Research Promotion
  • MEXT Funds for the Development of Human Resources in Science and Technology, “Initiative for Realizing Diversity in the Research Environment (Characteristic-Co…

Zitieren

APA

Narita, A., Nakano-Doi, A., Nishiyama, R., Sawano, T., Fukushima, K., Matsuyama, T., & Nakagomi, T. (2026). Mirtazapine Induces Lipocalin-Type Prostaglandin D Synthase Expression in Brain Pericytes. Biomolecules, 16(7), 945. https://doi.org/10.3390/biom16070945

Vancouver

Narita A, Nakano-Doi A, Nishiyama R, Sawano T, Fukushima K, Matsuyama T, et al. Mirtazapine Induces Lipocalin-Type Prostaglandin D Synthase Expression in Brain Pericytes. Biomolecules. 2026;16(7):945. doi:10.3390/biom16070945

BibTeX
@article{Narita2026,
  author = {Narita, Aya and Nakano-Doi, Akiko and Nishiyama, Ryo and Sawano, Toshinori and Fukushima, Kazuaki and Matsuyama, Tomohiro and Nakagomi, Takayuki},
  title = {Mirtazapine Induces Lipocalin-Type Prostaglandin D Synthase Expression in Brain Pericytes},
  journal = {Biomolecules},
  year = {2026},
  volume = {16},
  number = {7},
  pages = {945},
  doi = {10.3390/biom16070945}
}
Kostenlos starten →